Hypoxia-induced Phenotypic Switch of Fibroblasts to Myofibroblasts through a Matrix Metalloproteinase 2/Tissue Inhibitor of Metalloproteinase-mediated Pathway: Implications for Venous Neointimal Hyperplasia in Hemodialysis Access

Journal of Vascular and Interventional Radiology

Volumn 21, Issue 6, 2010, Pages 896-902

  Misra, Sanjay ^a   Fu, Alex A ^a   Misra, Khamal D ^a   Shergill, Uday M ^a   Leof, Edward B ^b   Mukhopadhyay, Debabrata ^b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; FIBRONECTIN; GELATINASE A; HYPOXIA INDUCIBLE FACTOR 1ALPHA; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; OXYGEN;

ANIMAL CELL; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL HYPOXIA; CELL TRANSFORMATION; CONTROLLED STUDY; FIBROBLAST; HEMODIALYSIS; IMMUNOHISTOCHEMISTRY; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULAR ACCESS; ANIMAL; CELL DIFFERENTIATION; CELL LINE; CYTOLOGY; DRUG EFFECTS; INTIMA; METABOLISM; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RENAL REPLACEMENT THERAPY; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; CELL HYPOXIA; CELL LINE; FIBROBLASTS; MATRIX METALLOPROTEINASE 2; MICE; OXYGEN; RENAL DIALYSIS; SIGNAL TRANSDUCTION; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TUNICA INTIMA;

EID: 77952321489     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2010.02.030     Document Type: Article

References (48)

1. Collins A.J., Kasiske B., Herzog C., et al. Excerpts from the United States Renal Data System 2003 Annual Data Report: atlas of end-stage renal disease in the United States. Am J Kidney Dis 42 (2003) A5-A7
2. Miller P.E., Carlton D., Deierhoi M.H., Redden D.T., and Allon M. Natural history of arteriovenous grafts in hemodialysis patients. Am J Kidney Dis 36 (2000) 68-74
3. Misra S., Bonan R., Pflederer T., and Roy-Chaudhury P. BRAVO I: a pilot study of vascular brachytherapy in polytetrafluoroethylene dialysis access grafts. Kidney Int 70 (2006) 2006-2013
4. Rekhter M., Nicholls S., Ferguson M., and Gordon D. Cell proliferation in human arteriovenous fistulas used for hemodialysis. Arterioscler Thromb 13 (1993) 609-617
5. Misra S., Doherty M.G., Woodrum D., et al. Adventitial remodeling with increased matrix metalloproteinase-2 activity in a porcine arteriovenous polytetrafluoroethylene grafts. Kidney Int 68 (2005) 2890-2900
6. Li L., Terry C.M., Blumenthal D.K., et al. Cellular and morphological changes during neointimal hyperplasia development in a porcine arteriovenous graft model. Nephrol Dial Transplant 22 (2007) 3139-3146
7. Misra S., Fu A., Rajan D., Juncos L., et al. Expression of hypoxia inducible factor-1 alpha, macrophage migration inhibition factor, matrix metalloproteinase-2 and -9, and their inhibitors in hemodialysis grafts and arteriovenous fistulas. J Vasc Interv Radiol 19 (2008) 252-259
8. Misra S., Fu A., Pugionni A., et al. Increased expression of hypoxia inducible factor-1a in a porcine model of chronic renal insufficiency with arteriovenous polytetrafluoroethylene grafts. J Vasc Interv Radiol 19 (2008) 260-265
9. Hughes D., Fu A.A., Puggioni A., et al. Adventitial transplantation of blood outgrowth endothelial cells in porcine haemodialysis grafts alleviates hypoxia and decreases neointimal proliferation through a matrix metalloproteinase-9-mediated pathway-a pilot study. Nephrol Dial Transplant 24 (2009) 85-96
10. Dean R.A., Butler G.S., Hamma-Kourbali Y., et al. Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens: disruption of vascular endothelial growth factor (VEGF)/heparin affinity regulatory peptide (pleiotrophin) and VEGF/connective tissue growth factor angiogenic inhibitory complexes by MMP-2 proteolysis. Mol Cell Biol 27 (2007) 8454-8465
11. Ito T.K., Ishii G., Chiba H., and Ochiai A. The VEGF angiogenic switch of fibroblasts is regulated by MMP-7 from cancer cells. Oncogene 26 (2007) 7194-7203
12. Zhong J., Gencay M.M., Bubendorf L., et al. ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells. J Cell Physiol 207 (2006) 540-552
13. Misra S., Fu A., Anderson J., Glockner J., et al. The rat femoral arteriovenous fistula model: Increased expression of MMP-2 and MMP-9 at the venous stenosis. J Vasc Interv Radiol 19 (2008) 587-594
14. Misra S., Fu A.A., Puggioni A., et al. Increased shear stress with up regulation of VEGF-A and its receptors and MMP-2, MMP-9, and TIMP-1 in venous stenosis of hemodialysis grafts. Am J Physiol Heart Circ Physiol 294 (2008) H2219-H2230
15. Rotmans J.I., Velema E., Verhagen H.J., et al. Matrix metalloproteinase inhibition reduces intimal hyperplasia in a porcine arteriovenous-graft model. J Vasc Surg 39 (2004) 432-439
16. Swedberg S.H., Brown B.G., Sigley R., Wight T.N., Gordon D., and Nicholls S.C. Intimal fibromuscular hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients: clinical, immunocytochemical, light and electron microscopic assessment. Circulation 80 (1989) 1726-1736
17. Hofstra L., Tordoir J.H., Kitslaar P.J., Hoeks A.P., and Daemen M.J. Enhanced cellular proliferation in intact stenotic lesions derived from human arteriovenous fistulas and peripheral bypass grafts. Does it correlate with flow parameters?. Circulation 94 (1996) 1283-1290
18. Roy-Chaudhury P., Kelly B.S., Miller M.A., et al. Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts. Kidney Int 59 (2001) 2325-2334
19. Roy-Chaudhury P., Sukhatme V.P., and Cheung A.K. Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint. J Am Soc Nephrol 17 (2006) 1112-1127
20. Shi Y., O'Brien J.E., Fard A., Mannion J.D., Wang D., and Zalewski A. Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation 94 (1996) 1655-1664
21. Shi Y., Patel S., Niculescu R., Chung W., Desrochers P., and Zalewski A. Role of matrix metalloproteinases and their tissue inhibitors in the regulation of coronary cell migration. Arterioscler Thromb Vasc Biol 19 (1999) 1150-1155
22. Shi Y., Pieniek M., Fard A., O'Brien J., Mannion J.D., and Zalewski A. Adventitial remodeling after coronary arterial injury. Circulation 93 (1996) 340-348
23. Scott N.A., Cipolla G.D., Ross C.E., et al. Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation 93 (1996) 2178-2187
24. Zalewski A., and Shi Y. Vascular myofibroblasts. Lessons from coronary repair and remodeling. Arterioscler Thromb Vasc Biol 17 (1997) 417-422
25. Kalra M., and Miller V.M. Early remodeling of saphenous vein grafts: proliferation, migration and apoptosis of adventitial and medial cells occur simultaneously with changes in graft diameter and blood flow. J Vasc Res 37 (2000) 576-584
26. Shi Y., O'Brien Jr. J.E., Mannion J.D., et al. Remodeling of autologous saphenous vein grafts. The role of perivascular myofibroblasts. Circulation 95 (1997) 2684-2693
27. Cai W.J., Koltai S., Kocsis E., et al. Remodeling of the adventitia during coronary arteriogenesis. Am J Physiol Heart Circ Physiol 284 (2003) H31-H40
28. Fillinger M., Reinitz E., Schwartz R., Resetarits D., Paskanik A., and Bredenberg C. Beneficial effects of banding on venous intimal-medial hyperplasia in arteriovenous loop grafts. Am J Surg 158 (1989) 87-94
29. Fillinger M., Reinitz E., Schwartz R., et al. Graft geometry and venous intimal-medial hyperplasia in arteriovenous loop grafts. J Vasc Surg 11 (1990) 556-566
30. Haruguchi H., and Teraoka S. Intimal hyperplasia and hemodynamic factors in arterial bypass and arteriovenous grafts: a review. J Artif Organs 6 (2003) 227-235
31. Heise M., Schmidt S., Kruger U., et al. Local haemodynamics and shear stress in cuffed and straight PTFE-venous anastomoses: an in-vitro comparison using particle image velocimetry. Eur J Vasc Endovasc Surg 26 (2003) 367-373
32. Hofstra L., Bergmans D.C., Hoeks A.P., Kitslaar P.J., Leunissen K.M., and Tordoir J.H. Mismatch in elastic properties around anastomoses of interposition grafts for hemodialysis access. J Am Soc Nephrol 5 (1994) 1243-1250
33. Keynton R., Evancho M., Sims R., Rodway N., Gobin A., and Rittgers S. Intimal hyperplasia and wall shear in arterial bypass graft distal anastomoses: an in vivo model study. J Biomech Eng 123 (2001) 464-473
34. Krueger U., Zanow J., and Scholz H. Computational fluid dynamics and vascular access. Artif Organs 26 (2002) 571-575
35. Meyerson S.L., Skelly C.L., Curi M.A., et al. The effects of extremely low shear stress on cellular proliferation and neointimal thickening in the failing bypass graft. J Vasc Surg 34 (2001) 90-97
36. Van Tricht I., De Wachter D., Tordoir J., and Verdonck P. Comparison of the hemodynamics in 6 mm and 4-7 mm hemodialysis grafts by means of CFD. J Biomechanics 39 (2006) 226-236
37. Nakata T., and Shionoya S. Vascular lesions due to obstruction of the vasa vasorum. Nature 212 (1966) 1258-1259
38. Santilli S.M., Tretinayak A.S., and Lee E.S. Transarterial wall oxygen gradients at the deployment site of an intra-arterial stent in the rabbit. Am J Physiol Heart Circ Physiol 279 (2000) H1518-H1525
39. Koong A.C., Denko N.C., Hudson K.M., et al. Candidate genes for the hypoxic tumor phenotype. Cancer Res 60 (2000) 883-887
40. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3 (2003) 721-732
41. Wang Y., Krishnamoorthy M., Banerjee R., et al. Venous stenosis in a pig arteriovenous fistula model anatomy, mechanisms and cellular phenotypes. Nephrol Dial Transplant 22 (2007) 3139-3146
42. Karakiulakis G., Papakonstantinou E., Aletras A.J., Tamm M., and Roth M. Cell type-specific effect of hypoxia and platelet-derived growth factor-BB on extracellular matrix turnover and its consequences for lung remodeling. J Biol Chem 282 (2007) 908-915
43. Leufgen H., Bihl M.P., Rudiger J.J., et al. Collagenase expression and activity is modulated by the interaction of collagen types, hypoxia, and nutrition in human lung cells. J Cell Physiol 204 (2005) 146-154
44. Papakonstantinou E., Aletras A.J., Roth M., Tamm M., and Karakiulakis G. Hypoxia modulates the effects of transforming growth factor-beta isoforms on matrix-formation by primary human lung fibroblasts. Cytokine 24 (2003) 25-35
45. Short M., Nemenoff R.A., Zawada W.M., Stenmark K.R., and Das M. Hypoxia induces differentiation of pulmonary artery adventitial fibroblasts into myofibroblasts. Am J Physiol Cell Physiol 286 (2004) C416-C425
46. Higgins D.F., Kimura K., Bernhardt W.M., et al. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest 117 (2007) 3810-3820
47. Stenmark K.R., Gerasimovskaya E., Nemenoff R.A., and Das M. Hypoxic activation of adventitial fibroblasts: role in vascular remodeling. Chest 122 Suppl (2002) 326S-334S
48. Das M., Dempsey E.C., Reeves J.T., and Stenmark K.R. Selective expansion of fibroblast subpopulations from pulmonary artery adventitia in response to hypoxia. Am J Physiol Lung Cell Mol Physiol 282 (2002) L976-L986